MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-23-0153151
Catapharma (India) Pvt Ltd - chemicals and materials in Nashik, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.6 Cr
▼ 83% YoY
Net profit · FY 2025
₹68.47 Lakh
Net margin 19%
EBITDA · FY 2025
₹80.91 Lakh
EBITDA margin 22.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8.45 Lakh
Issued & subscribed
Open charges
₹4.55 Cr
Secured borrowings
Company age
40 yrs
Est. 1986
Directors on board
2
As per MCA filings
About Catapharma (India) Pvt Ltd
Data last updated:
Catapharma (India) Pvt Ltd is a private limited company based in Nashik, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 29 October 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1986PTC041424. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.45 Lakh. It is led by directors Shrikant Laxminarayan Karwa (Managing Director) and Manju Shrikant Karwa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Catapharma House S. No. 28/6/3 Ghadge Nagar Opp. Swimming Pool Nashik Road, Maharashtra, India – 422101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.6 Cr, a decline of 83% compared to the previous year. For the same year it recorded a net profit of ₹68.47 Lakh (net margin 19%) and EBITDA of ₹80.91 Lakh (EBITDA margin 22.5%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 52% over five years.
The company is associated with 1 brand: Catapharma. As per MCA filings, the company has open charges of ₹4.55 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
Catapharma (India) Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0153151). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website catapharma.com.
Company details
CIN U99999MH1986PTC041424
Registration Number 041424
Incorporation Date 29 October 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-23-0153151
CIN history
Catapharma (India) has one previous CIN (Corporate Identification Number): U99999MH2004PTC041424. The current CIN is U99999MH1986PTC041424, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999MH1986PTC041424 | Current |
| U99999MH2004PTC041424 | Previous |
Recognitions & Rankings of Catapharma (India)
Contact details
Catapharma (India) Pvt Ltd's registered office is in Nashik, Maharashtra. Its website is catapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressCatapharma House S. No. 28/6/3 Ghadge Nagar Opp. Swimming Pool Nashik Road, Maharashtra, India – 422101
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Catapharma (India) Pvt Ltd, buy the company report.
Comprehensive company report
Catapharma (India) Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Catapharma (India) operates one associated brand: Catapharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality bulk drugs and intermediates with expertise in liquid-phase hydrogenation. | catapharma.com |
Business activity
The main business activity of Catapharma (India) is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Catapharma (India) Pvt Ltd, buy the company report.
Financials of Catapharma (India) Pvt Ltd
FY 2025 filings availableCatapharma (India) Pvt Ltd reported revenue of ₹3.6 Cr (down 83% YoY) for FY 2025.
Revenue · FY 2025
₹3.6 Cr ▼ 83%
Net profit · FY 2025
₹68.47 Lakh margin 19%
EBITDA · FY 2025
₹80.91 Lakh margin 22.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 83%
3 years · compounded
▼ 37%
5 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 27%
5 years · compounded
▲ 23%
Revenue fell 83% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹80.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.5% | ||||
| Net Profit Margin | 19% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Catapharma (India) Pvt Ltd, buy the company report.
Board of directors of Catapharma (India) Pvt Ltd
Catapharma (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Shrikant Karwa Also directs: Catapro Pharmalab Private Limited, Dr. Shrikant Karwa Foundation | Director | 18 Feb 2021 | 5 Years 8 Months | Current |
| Shrikant Laxminarayan Karwa Also directs: Catapro Pharmalab Private Limited, Catapharma Chemicals Private Limited, MDB Chemicals (India) Private Limited and 2 more | Managing Director | 29 Oct 1986 | 39 Years 11 Months | Current |
Peer comparison
Catapharma (India) Pvt Ltd is compared with the 3 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Frederick and Machtig Industries Private Limited | ₹3.6 Cr (FY 2025) | 19.0% | Ahmedabad, Gujarat, India | |||
| Magrax Enterprises Private Limited | ₹3.6 Cr (FY 2025) | -22.0% | Faridabad, Haryana, India | |||
| Catapharma (India) Pvt Ltdthis company | ₹3.6 Cr (FY 2025) | ₹68.47 Lakh | 19% | -83.0% | Nashik, Maharashtra, India | |
| Riddhi Siddhi Fuels Private Limited | ₹3.57 Cr (FY 2025) | -9.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Catapharma (India) Pvt Ltd, buy the company report.
Auditor
Catapharma (India) Pvt Ltd is audited by Natesh &Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Natesh &Associates | FY 2023 | 106957W |
Shareholding
The shareholding of Catapharma (India) Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Catapharma (India) Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹4.55 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Apr 2021 | 100440479 | Others | ₹2 Cr | Open | |
| 23 Dec 1994 | 90375731 | Bank of India | ₹2.45 Cr | Open | |
| 27 Jun 1994 | 90375670 | Dena Bank | ₹10 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Catapharma (India) Pvt Ltd has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Income-Tax | Disposed |
To see the full case history of Catapharma (India) Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Catapharma (India) Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Catapharma (India) has 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Associated companies
GST
Catapharma (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Catapharma (India) Pvt Ltd, buy the company report.
Recent activity
Catapharma (India) Pvt Ltd has 3 board changes on record since 1986: 2 appointments and 1 cessation. The latest: Pravin Shriram Marawar ceased to be Director on 17 Nov 2021.
AGM
Catapharma (India) Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Catapharma (India) Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Pravin Shriram Marawar ceased to be Director.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100440479 was registered on 23 Apr 2021.
Appointed
Manju Shrikant Karwa was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 245.00 Lakh with Charge ID 90375731 was registered on 23 Dec 1994.
Charges
A charge with Dena Bank amounted to Rs. 10.00 Lakh with Charge ID 90375670 was registered on 27 Jun 1994.
Appointed
Shrikant Laxminarayan Karwa was appointed as Managing Director.
Incorporation
29 Oct 1986
Catapharma (India) Pvt Ltd was registered on 29 Oct 1986 with Roc Mumbai & aged 39 years 11 months as per MCA records.
Frequently asked questions
Catapharma (India) is an active private limited company based in Nashik, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 29 October 1986 (40+ years old) and is registered under CIN U99999MH1986PTC041424.
Catapharma (India) has 2 current directors:
- Shrikant Laxminarayan Karwa - Managing Director
- Manju Shrikant Karwa - Director
The latest financial statements of Catapharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Catapharma (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Catapharma (India) is U99999MH1986PTC041424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Catapharma (India) has 2 court cases on record: 2 filed against it.
Catapharma (India) was incorporated on 29 October 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Catapharma (India) by revenue are Frederick and Machtig Industries Private Limited, Magrax Enterprises Private Limited, Riddhi Siddhi Fuels Private Limited, all in the Chemicals industry (Chemical Retail and Distribution), with the same principal business activity (retail trading).
Pravin Shriram Marawar ceased to be Director on 17 Nov 2021. Manju Shrikant Karwa was appointed as Director on 18 Feb 2021. Shrikant Laxminarayan Karwa was appointed as Managing Director on 29 Oct 1986.
Yes, Catapharma (India) is registered as a small enterprise under Udyam registration (number: UDYAM-MH-23-0153151).
Catapharma (India) can be reached through the website catapharma.com. Its registered office is in Nashik, Maharashtra, India.